Protein splicing is a self‐catalyzed process in which an internal protein domain (the intein) is excised from its flanking sequences, linking them together with a canonical peptide bond. Trans‐inteins are separated in two different precursor polypeptide chains that must assemble to catalytically self‐excise and ligate the corresponding flanking exteins to join even when expressed separately either in vitro or in vivo. They are very interesting to construct full proteins from separate domains because their common small size favors chemical synthesis approaches. Therefore, trans‐inteins have multiple applications such as protein modification and purification, structural characterization of protein domains or production of intein‐based biosensors, among others. For many of these applications, when using more than one trans‐intein, orthogonality between them is a critical issue to ensure the proper ligation of the exteins. Here, we confirm the orthogonality (lack of cross‐reactivity) of four different trans‐ or split inteins, gp41‐1, gp41‐8, IMPDH‐1 and NrdJ‐1 both in vivo and in vitro, and built different constructs that allow for the sequential fusion of up to four protein fragments into one final spliced product. We have characterized the splicing efficiency of these constructs. All harbor non‐native extein residues at the splice junction between the trans‐intein and the neighboring exteins, except for the essential Ser + 1. Our results show that it is possible to ligate four different protein domains using inteins gp41‐1, IMPDH‐1 and NrdJ‐1 with non‐native extein residues to obtain a final four‐domain spliced product with a not negligible yield that keeps its native sequence.